These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8218732)

  • 21. The preparation and characterization of poly(D,L-lactic acid) for use as a biodegradable drug carrier.
    Rak J; Ford JL; Rostron C; Walters V
    Pharm Acta Helv; 1985; 60(5-6):162-9. PubMed ID: 4023019
    [No Abstract]   [Full Text] [Related]  

  • 22. Microencapsulation using poly(DL-lactic acid). III: Effect of polymer molecular weight on the release kinetics.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(3):357-74. PubMed ID: 2384838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biodegradation of PLA/GA polymers: increasing complexity.
    Vert M; Mauduit J; Li S
    Biomaterials; 1994 Dec; 15(15):1209-13. PubMed ID: 7703316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
    Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
    J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High glycolic poly (DL lactic co glycolic acid) nanoparticles for controlled release of meropenem.
    Nandakumar V; Geetha V; Chittaranjan S; Doble M
    Biomed Pharmacother; 2013 Jun; 67(5):431-6. PubMed ID: 23583192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative assessment of in vitro release kinetics of calcitonin polypeptide from biodegradable microspheres.
    Prabhu S; Sullivan JL; Betageri GV
    Drug Deliv; 2002; 9(3):195-8. PubMed ID: 12396737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study on the in vitro degradation of poly(lactic acid).
    Migliaresi C; Fambri L; Cohn D
    J Biomater Sci Polym Ed; 1994; 5(6):591-606. PubMed ID: 8086385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biodegradable controlled antibiotic release devices for osteomyelitis: optimization of release properties.
    Zhang X; Wyss UP; Pichora D; Goosen MF
    J Pharm Pharmacol; 1994 Sep; 46(9):718-24. PubMed ID: 7837040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biodegradable poly (lactic acid) microspheres for drug delivery systems.
    Hyon SH
    Yonsei Med J; 2000 Dec; 41(6):720-34. PubMed ID: 11204823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preparation of biodegradable and sustained release gel of tinidazole].
    Qin Y; Li L; Li W; Yuan M; Zhu Y; Guo S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Feb; 24(1):87-90. PubMed ID: 17333898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Degradation of polydispersed poly(L-lactic acid) to modulate lactic acid release.
    von Recum HA; Cleek RL; Eskin SG; Mikos AG
    Biomaterials; 1995 Apr; 16(6):441-7. PubMed ID: 7654870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biodegradable block copolymers as injectable drug-delivery systems.
    Jeong B; Bae YH; Lee DS; Kim SW
    Nature; 1997 Aug; 388(6645):860-2. PubMed ID: 9278046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A basic study on usefulness of bleomycin incorporated in poly DL-lactic acid].
    Kumanohoso T; Natsugoe S; Shimada M; Sagara M; Aikou T; Shimazu H; Shinkawa T; Nakamura K; Fukuzaki H
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1572-4. PubMed ID: 7690536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained release of antimicrobials in the middle ear using a biodegradable support.
    Goycoolea MV; Muchow DC
    Ann Otol Rhinol Laryngol Suppl; 1994 May; 163():46-8. PubMed ID: 8179270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route.
    Lalla JK; Sapna K
    J Microencapsul; 1993; 10(4):449-60. PubMed ID: 8263674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The preparation of poly (DL-lactide) hollow fiber and the release of drug in vitro].
    Zhu J; Shen Z; Ma Z; Wu L; Shi D
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 1997 Sep; 14(3):247-51. PubMed ID: 11326842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vivo degradation of poly(lactic acid) of different molecular weights.
    Chawla AS; Chang TM
    Biomater Med Devices Artif Organs; 1985-1986; 13(3-4):153-62. PubMed ID: 3841816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dielectric and thermodynamic properties of biodegradable poly(D,L-lactide-co-glycolide) and the effect on the micro-encapsulation and release of captopril.
    Schartel B; Volland C; Li YX; Wendorff JW; Kissel T
    J Microencapsul; 1997; 14(4):475-88. PubMed ID: 9229347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preparations of drug-loaded poly(lactic acid) nanoparticles].
    Deng LD; Sun DX; Dong AJ
    Zhongguo Zhong Yao Za Zhi; 2002 Jul; 27(7):496-8. PubMed ID: 12846214
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro and in vivo release of poly(DL-lactic acid) microspheres containing neurotensin analogue prepared by novel oil-in-water solvent evaporation method.
    Yamakawa I; Tsushima Y; Machida R; Watanabe S
    J Pharm Sci; 1992 Aug; 81(8):808-11. PubMed ID: 1403728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.